Accelerating the development of biomarkers for drug safety workshop summary

"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and prov...

Full description

Bibliographic Details
Main Author: Institute of Medicine (U.S.).
Corporate Authors: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation (-), National Research Council (U.S.). Planning Committee for Assessing and Accelerating the Development of Biomarkers for Drug Safety : a Workshop, Assessing and Accelerating the Development of Biomarkers for Drug Safety. Workshop
Other Authors: Giffin, Robert B. (-), Olson, Steve, 1956-, Robinson, Sally
Format: eBook
Language:Inglés
Published: Washington, D.C. : National Academies Press c2009.
Edition:1st ed
Subjects:
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622339306719
Description
Summary:"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held 'Assessing and Accelerating Development of Biomarkers for Drug Safety,' a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development."--Publisher's website.
Item Description:Bibliographic Level Mode of Issuance: Monograph
Physical Description:1 online resource (99 p.)
Bibliography:Includes bibliographical references (p. 55-57).
ISBN:9780309142311
9781282272651
9786612272653
9780309131254